These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The clinico-immunological effects of leukinferon in the treatment of patients with acute suppurative pyelonephritis]. Vozianov AS; Kuznetsova VP; Driianskaia VE; Pasechnikov SP; Ozvinchuk II; Musiĭ MIa; Fedorchuk GV; Beliaev DL; Dranik GN Urol Nefrol (Mosk); 1994; (3):8-11. PubMed ID: 8079417 [TBL] [Abstract][Full Text] [Related]
4. [The clinico-immunological effects of leukinferon in the treatment of patients with acute suppurative pyelonephritis]. Vozianov AF; Kuznetsov VP; Driianskaia VE; Pasechnikov SP; Ozvinchuk II; Fedoruk GV; Drannik GN Lik Sprava; 1997; (1):88-92. PubMed ID: 9221157 [TBL] [Abstract][Full Text] [Related]
5. [Leukinferon in the treatment of patients with acute viral hepatitis b]. Golban TD; Cheshin SG; Kuznetsov VP; Farber NA; Beliaev DL; Kirzhner LS; Babaiants AA; Vasina VI Klin Med (Mosk); 1994; 72(3):27-9. PubMed ID: 7990347 [TBL] [Abstract][Full Text] [Related]
6. [Experience of immunotherapy with leukinferon in the comprehensive therapy of breast cancer]. Korobkova LI; Kuznetsov VP; Rasskazchikova ES; Beliaev DL; Vel'sher LZ; Babadiants AA; Zverev MP; Strekalovskiĭ SV; Zueva LA Vopr Onkol; 1994; 40(7-12):309-13. PubMed ID: 7610626 [TBL] [Abstract][Full Text] [Related]
7. [Leukinferon in the comprehensive therapy of sepsis in newborns]. Nesterov VV; Beliaev DL; Kuznestov VP Antibiot Khimioter; 1993 Jan; 38(1):62-8. PubMed ID: 8060187 [TBL] [Abstract][Full Text] [Related]
8. [The use of leukinferon in treating zoonotic cutaneous leishmaniasis. 1. Research on an experimental model in mice]. Shuĭkina EE; Sergiev VP; Kuznetsov VP; Beliaev DL; Fediainova IE Med Parazitol (Mosk); 1993; (2):28-31. PubMed ID: 8028564 [TBL] [Abstract][Full Text] [Related]
12. [Leukinferon in the treatment of patients with sepsis and multiple organ dysfunction syndrome]. Kuznetsov VP; Markelova EV; Smirnov GA; Lazanovich VA; Beliaev DL Antibiot Khimioter; 2002; 47(5):3-7. PubMed ID: 12365325 [TBL] [Abstract][Full Text] [Related]
13. [The use of a complex preparation of alpha-interferon and first-phase immune-response cytokines--leukinferon]. Gruzdeva TA; Kuznetsov VP; Beliaev DL; Vakhman IS; Fedorova NV; Babaiants AA; Polikarpova EV Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):59-64. PubMed ID: 8184616 [TBL] [Abstract][Full Text] [Related]
14. [Approaches to the combined therapy of helminthiases with leukinferon and etiotropic preparations]. Lebedeva MN; Malysheva NS; Fedianina LV; Shuĭkina EE; Gitsu GA Med Parazitol (Mosk); 1998; (1):15-7. PubMed ID: 9608202 [TBL] [Abstract][Full Text] [Related]
15. [Use of leukinferon for prophylaxis of pyogenic complications in victims with thoracic wounds]. Bulava GV; Abakumov MM; Druzenko OA; Markova OA; Pogodina AN; Khvatov VB Khirurgiia (Mosk); 1999; (7):35-9. PubMed ID: 10459185 [TBL] [Abstract][Full Text] [Related]
16. [The combined therapy of patients with gonorrheal-chlamydial urogenital infections by leukinferon immunocorrection]. Kuznetsov VP; Dubenskiĭ VV; Delektorskiĭ VV; Igoshin IuM; Beliaev DL; Iashkova GN; Babaiants AA Ter Arkh; 1993; 65(11):39-42. PubMed ID: 8108795 [TBL] [Abstract][Full Text] [Related]